Lars-Olof Wahlund has a long standing high level contribution in the field of dementia and AD. The research group focuses on early diagnostics in dementia and Alzheimer´s disease. Main focus is neuroimaging and MRI. Close collaboration with preclinical and epidemiological competence locally, nationally and internationally. The group has long experience in clinical trials on anti dementia treatment. The research group was the first to publish a clinical trial on Omega 3 fatty acid and Alzheimer’s disease in October 2006. It is obvious from this that this group is a partner of this consortium.
| Contact Prof. Lars-Olof Wahlund Karolinska Institutet Department of Neurobiology, Care Sciences and Society Division of Clinical Geriatrics Novum 5th floor 141 86 Stockholm (Sweden) Tel: +46-8-585-8541-9 Fax: +46-8-585-8547-0 E-Mail: lars-olof.wahlund(at)ki.se URL: http://ki.se/ki/jsp/polopoly.jsp?l=en&d=7877
|


| Contact Dr. Miia Kivipelto Karolinska Institutet Division of Geriatric Epidemiology Novum 5th floor 141 86 Stockholm (Sweden) Tel: +46-73-994-0922 Fax: +46-8-585-8547-0 E-Mail: Miia.Kivipelto(at)ki.se
|


| Contact Dr. Yvonne Freund-Levi, M.D. Lic. Cognitive Psycotherapist Karolinska Institutet Department of Neurobiology, Care Sciences and Society Division of Clinical Geriatrics Novum 5th floor Karolinska University Hospital 114 86 Stockholm (Sweden) Tel: +46-8-585-8547-2 E-Mail: Yvonne.Freund-Levi(at)ki.se URL: http://ki.se/ki/jsp/polopoly.jsp?a=39615&d=7877&l=sv
|

